Results 181 to 190 of about 74,509 (297)

Management of paediatric ulcerative colitis, part 1: Ambulatory care—An updated evidence‐based consensus guideline from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition and the European Crohn's and Colitis Organisation

Journal of Pediatric Gastroenterology and Nutrition, Volume 81, Issue 3, Page 765-815, September 2025.
Abstract Objectives Despite advances in the management of ambulatory paediatric ulcerative colitis (UC), challenges remain as many patients are refractory to therapy and some require colectomy. The aim of these guidelines is to provide an update on optimal care for UC through detailed recommendations and practice points. Methods These guidelines are an
Eytan Wine, Marina Aloi, Stephanie Van Biervliet, Jiri Bronsky, Javier Martín di Carpi, Marco Gasparetto, Laura Gianolio, Hannah Gordon, Iva Hojsak, Alexandra S. Hudson, Séamus Hussey, Johan van Limbergen, Erasmo Miele, Lorenzo Norsa, Ola Olén, Gianluca Pellino, Patrick van Rheenen, Lissy de Ridder, Richard K. Russell, Dror S. Shouval, Eunice Trindade, Dan Turner, David C. Wilson, Anat Yerushalmy Feler, Amit Assa   +24 more
wiley   +1 more source

Pharmacogenomics: marshalling the human genome to individualise drug therapy [PDF]

, 2003
William E. Evans
openalex   +1 more source

Zebrafish as a Versatile Model Organism: From Tanks to Treatment

MedComm – Future Medicine, Volume 4, Issue 3, September 2025.
The zebrafish, with its optical transparency and genetic tractability, serves as a versatile in vivo platform for biomedical research. This review underscores its significance in modeling a wide spectrum of human diseases—from cancer to metabolic disorders—and in leveraging cutting‐edge technologies like CRISPR and TALENs.
Rupali Srivastava, Kalyani Eswar, Sasvat Sayee Ram Ramesh, Akshit Prajapati, Tanvi Sonpipare, Apoorva Basa, Mounika Gubige, Sribala Ponnapalli, Shashidhar Thatikonda, Aravind Kumar Rengan   +9 more
wiley   +1 more source

Correction: Integrating rare genetic variants into DPYD pharmacogenetic testing may help preventing fluoropyrimidine-induced toxicity. [PDF]

Pharmacogenomics J
Larrue R, Fellah S, Hennart B, Sabaouni N, Boukrout N, Van der Hauwaert C, Delage C, Cheok M, Perrais M, Cauffiez C, Allorge D, Pottier N.   +11 more
europepmc   +1 more source

Cardiovascular Pharmacogenomics: Current Status, Future Prospects [PDF]

, 2003
Jeffrey L. Anderson, John F. Carlquist, Benjamin D. Home, Joseph B Muhlestein   +3 more
openalex   +1 more source

Science of omics: a molecular space odyssey

Experimental Physiology, EarlyView.
Salomé Coppens, Christophe Hirtz, Margaux Vignon, Damian M. Bailey   +3 more
wiley   +1 more source

Access and benefit sharing biological materials for machines: Artificial intelligence, machine learning and deep learning

PLANTS, PEOPLE, PLANET, Volume 7, Issue 5, Page 1485-1497, September 2025.
Future research and development of biological materials for foods, feeds, fibres, materials and medicines will increasingly rely on information and knowledge using Artificial Intelligence (AI) applications for detecting patterns to make useful decisions.
Charles Lawson, Elizabeth Englezos, Michelle Rourke   +2 more
wiley   +1 more source

Opportunities and Challenges of Population Pharmacogenomics

Annals of Human Genetics, Volume 89, Issue 5, Page 384-397, September 2025.
ABSTRACT Pharmacological responses can vary significantly among patients from different ethnogeographic backgrounds. This variability can, at least in part, be attributed to population‐specific genetic patterns in genes involved in drug absorption, distribution, metabolism, and excretion, as well as in genes associated with drug‐induced toxicity ...
Yitian Zhou, Yoomi Park, Mahamadou D. Camara, Volker M. Lauschke   +3 more
wiley   +1 more source

Pharmacogenomics: Genetic Polymorphism of Receptors and Variation in Drug Response.

, 2001
Gozoh Tsujimoto
openalex   +2 more sources

Pharmacogenetics and Pharmacogenomics in Drug Development and Regulatory Decision Making: Report of the First FDA‐PWG‐PhRMA‐DruSafe Workshop [PDF]

, 2003
Lawrence J. Lesko, Ronald A. Salerno, Brian B. Spear, Donald C. Anderson, Timothy S. Anderson, C. Brazell, Jerry M. Collins, Andrew J. Dorner, David M. Essayan, Baltazar Gomez‐Mancilla, Joseph Hackett, Shiew‐Mei Huang, Susan Ide, Joanne Killinger, John K. Leighton, Elizabeth Mansfield, Robert J. Meyer, Stephen G. Ryan, Virginia D. Schmith, Peter Shaw, Frank D. Sistare, Mark L Watson, Alexandra S. Worobec   +22 more
openalex   +1 more source